![Henri Lichenstein](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Henri Lichenstein
Founder at Shanghai Drug Farm Biological Technology Co., Ltd.
Profile
Henri S.
Lichenstein was the founder of OrphAI Therapeutics, Inc. (founded in 2013) and Shanghai Drug Farm Biological Technology Co., Ltd.
(founded in 2015), where he held the titles of President & Chief Executive Officer and Chief Executive Officer & Director, respectively.
He was also a former Vice President-Product Development at CuraGen Corp.
and a former Chief Development Officer at Topotarget A.
Henri Lichenstein active positions
Companies | Position | Start |
---|---|---|
Shanghai Drug Farm Biological Technology Co., Ltd.
![]() Shanghai Drug Farm Biological Technology Co., Ltd. Information Technology ServicesTechnology Services Shanghai Drug Farm Biological Technology Co., Ltd. is a Chinese private biotechnology company that focuses on developing innovative treatments for hepatitis B, heart and kidney diseases, and ROSAH syndrome. The company utilizes breakthrough technologies in genetics and AI to discover new treatments through its unique IDinVivo platform. This platform allows the direct assessment of gene targets in living animals with intact immune systems, which has led to the identification of novel innate immunity pathways and targets. Drug Farm is now advancing multiple first-in-class drug candidates into clinical development. | Founder | 20/10/2015 |
Former positions of Henri Lichenstein
Companies | Position | End |
---|---|---|
TOPOTARGET A/S | Corporate Officer/Principal | - |
AI Therapeutics, Inc.
![]() AI Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OrphAI Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The firm engages in matching drugs to diseases and identifying the care for individual patients using Guardian Angel Artificial Intelligence algorithm. The company was founded by Tian Xu, Jonathan M. Rothberg and Henri S. Lichenstein in 2013 and is headquartered in Guilford, CT. | Chief Executive Officer | 30/04/2021 |
CuraGen Corp.
![]() CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Corporate Officer/Principal | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 4 |
---|---|
CuraGen Corp.
![]() CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Health Technology |
Topotarget A/S
![]() Topotarget A/S Pharmaceuticals: MajorHealth Technology Topotarget A/S is a biotechnology company that is engaged in the development and commercialization of novel drugs for the treatment of cancer. Its product belinostat is a novel histone deacetylase inhibitor which is used for cancer patients. The company was founded by Peter Buhl Jensen and Maxwell Sehested in 2000 and is headquartered in Copenhagen, Denmark. | Health Technology |
AI Therapeutics, Inc.
![]() AI Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology OrphAI Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. The firm engages in matching drugs to diseases and identifying the care for individual patients using Guardian Angel Artificial Intelligence algorithm. The company was founded by Tian Xu, Jonathan M. Rothberg and Henri S. Lichenstein in 2013 and is headquartered in Guilford, CT. | Health Technology |
Shanghai Drug Farm Biological Technology Co., Ltd.
![]() Shanghai Drug Farm Biological Technology Co., Ltd. Information Technology ServicesTechnology Services Shanghai Drug Farm Biological Technology Co., Ltd. is a Chinese private biotechnology company that focuses on developing innovative treatments for hepatitis B, heart and kidney diseases, and ROSAH syndrome. The company utilizes breakthrough technologies in genetics and AI to discover new treatments through its unique IDinVivo platform. This platform allows the direct assessment of gene targets in living animals with intact immune systems, which has led to the identification of novel innate immunity pathways and targets. Drug Farm is now advancing multiple first-in-class drug candidates into clinical development. | Technology Services |
- Stock Market
- Insiders
- Henri Lichenstein